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Abstract
Carbon nanotubes (CNTs) have been proposed as one of the most promising nanomaterials to be 
used in biomedicine for their applications in drug/gene delivery as well as biomedical imaging. 
The present study developed radio-labeled iron oxide decorated multi-walled CNTs (MWNT) as 
dual magnetic resonance (MR) and single photon emission computed tomography (SPECT) 
imaging agents. Hybrids containing different amounts of iron oxide were synthesized by in situ 
generation. Physicochemical characterisations revealed the presence of superparamagnetic iron 
oxide nanoparticles (SPION) granted the magnetic properties of the hybrids. Further 
comprehensive examinations including high resolution transmission electron microscopy 
(HRTEM), fast Fourier transform simulations (FFT), X-ray diffraction (XRD) and X-ray 
photoelectron spectroscopy (XPS) assured the conformation of prepared SPION as γ-Fe2O3. High 
r2 relaxivities were obtained in both phantom and in vivo MRI compared to the clinically approved 
SPION Endorem®. The hybrids were successfully radio-labeled with technetium-99m through a 
functionalized bisphosphonate and enabled SPECT/CT imaging and γ-scintigraphy to 
quantitatively analyze the biodistribution in mice. No abnormality was found by histological 
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examination and the presence of SPION and MWNT were identified by Perls stain and Neutral 
Red stain, respectively. TEM images of liver and spleen tissues showed the co-localization of 
SPION and MWNT within the same intracellular vesicles, indicating the in vivo stability of the 
hybrids after intravenous injection. The results demonstrated the capability of the present SPION-
MWNT hybrids as dual MRI and SPECT contrast agents for in vivo use.
Graphic abstract
Dual SPECT and MR imaging of SPION-MWNT hybrids phantoms—Fe2O3-MWNT 
hybrids were dispersed in 1% Pluronic® F-127 solution and imaged by MR or SPECT/CT
Keywords
carbon nanotubes; magnetic nanoparticles; MRI; SPECT; dual imaging
Introduction
Nanomaterials constitute a new class of imaging agents in biomedical imaging. Because of 
the possession of large surface area per unit and the capability of further engineering, they 
often serve as a platform to facilitate imaging via the incorporation, either covalently or non-
covalently, of various imaging probes such as fluorophores, radiotracers or MR imaging 
contrast agents [1-4]. Carbon nanotubes (CNTs) are considered as one of the most promising 
nanomaterials to be used for biomedicine applications as delivery vectors for drugs or 
genes [5-7]. CNTs have also been employed for in vivo imaging either through conventional 
linking to the above mentioned imaging molecules or can be captured directly using Raman 
spectroscopy [8], near-Infrared (NIR) fluorescence microscopy [9], photoacoustic 
imaging [10] or ultrasonography [11] all relying on their inherent physical properties. 
However, satisfactory sensitivity and spatial resolution remain the major challenges.
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Although optical imaging is still the leading imaging modality in laboratory-based 
biomedical research mainly due to its convenience and low cost [12], magnetic resonance 
imaging (MRI) and nuclear imaging are currently the mainstream clinical diagnostic 
approaches. MRI is already a standard medical imaging technique which offers excellent 
spatial and temporal resolution, and good soft tissue contrast [13]. Nuclear imaging including 
single photon emission computed tomography (SPECT) and positron emission tomography 
(PET) involves the use of radioisotopes and has the advantages over other modalities of high 
sensitivity and the possibility to perform functional imaging [14]. The concept to establish 
multimodality imaging techniques is not new since each imaging modality has its own 
strength and weaknesses. From material scientists’ points of view, efforts have been made in 
the development of multimodal imaging contrast agents [15]. Here we propose magnetically 
decorated multi-walled CNTs (MWNTs) as dual MRI and SPECT contrast agents.
Many studies have been conducted to employ CNTs for MRI by incorporating paramagnetic 
gadolinium (Gd3+) or superparamagnetic iron oxide nanoparticles (SPION) into 
CNTs [16-22]. The two contrast agents are both clinically approved although showing 
opposite effect on a MR image. Gd3+ serves mainly as a positive contrast agent which 
increases proton spin-lattice relaxation rates (R1); iron oxide instead is a negative contrast 
agent by increasing spin-spin proton transverse relaxation rates R2 and R2*. Although Gd3+-
based contrast agents (GBC) are generally considered safe after chemical conjugation with 
organic chelating ligands, concern remains in their in vivo stability as free gadolinium ions 
are toxic[23]. There are also reports of adverse effects on using GBC in patients with 
impaired renal function [24]. In this regard, iron oxide nanoparticles which exhibit 
superparamagnetic properties have been used as negative MRI contrast agents in the clinic 
since they are biodegradable and can be incorporated into normal iron metabolism in the 
body [25, 26]. A Gd3+-conjugated ultra-short single-walled CNTs (SWNTs) nanocomposite 
was reported as a CNT-based MRI contrast agent for the first time in 2005 [16]. Together 
with a subsequent study [17], this type of Gd3+-SWNTs induced low toxicity in vitro and 
reported both high R1 and R2 relaxation properties. The first approach to employ CNT/iron 
oxide for MR imaging was described by Choi et al. who utilized Fe(CO)5 as the iron-
containing catalyst precursor for the growth of SWNTs [18]. The process resulted in the 
attachment of iron oxide nanoparticles to one end of the nanotubes, allowing MR imaging. 
The constructs were imaged using MRI and NIR spectroscopy in cells. CNTs/iron oxide 
hybrids applied for in vivo MRI were also recently studied by Wu et al. in the form of 
MWNT-Fe3O4 hybrids [19]. The hybrids accumulated in lung, liver and spleen and the R2-
weighted MRI revealed significantly reduced signals in liver and spleen. Chen and the 
colleagues developed a ‘layer-by-layer’ approach to assemble CNTs/iron oxide hybrids with 
quantum dots for in vitro magnetic-fluorescence dual imaging [20]. There was also a study 
using carboxylated SWNTs containing traces of iron for in vivo MRI [21]. Recently, Yin et 
al. demonstrated an in vitro targeting effect of CNTs/iron hybrids conjugated to the tumour 
targeting ligand folic acid [22]. Targeted constructs accumulated more in folate receptor 
positive cells compared to the non-targeted counterparts and thus displayed a darker MR 
image.
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Since SPION has been shown to be an effective MRI contrast agent, there have been studies 
to broaden the potential of iron oxide in biomedical imaging - by merging with a 
radionuclide to combine MRI and SPECT/PET [27-36]. Such integration was often performed 
through polymeric coating which may not have desirable stability, especially in vivo [31, 32]. 
A new approach has been introduced by de Rosales et al. using bisphosphonates (BPs) to 
link SPION with radionuclides [33, 35, 36]. With regards to the strong binding ability of BPs 
to the surface of SPION, radiolabelled-BPs were successfully conjugated to the iron oxide 
core and permitted quantitative biodistribution studies as well as dual SPECT/PET-MR 
imaging [33, 35, 36].
In the present study, we have exploited this novel approach to synthesize magnetic yet 
radioactive MWNTs as dual MRI and SPECT contrast agents. To the best of our knowledge, 
this is the first study documenting the use of CNTs/iron oxide hybrids for dual MRI and 
nuclear imaging. In this work, the R2* magnetic properties and the efficiency of radio-
labelling SPION/MWNT hybrids were examined. In vivo experiments were performed to 
characterize the hybrids as multimodal SPECT and MRI contrast agents.
Results
Synthesis of SPION-MWNT hybrids
The as-received MWNT materials were firstly purified by steam and HCl to remove some 
impurities, namely amorphous carbon, graphitic particles (carbon nanomaterials having few 
graphitic layers) and some metal particles. These metal particles, from the catalyst used for 
the growth of the MWNT, are covered by graphitic shells which inhibit their direct 
dissolution in an acidic media. Steam removed the amorphous carbon present in the samples 
and the graphitic shells covering the metal particles [37]. The removal of the amorphous 
carbon is essential to allow an efficient sidewall functionalization of the carbon 
nanotubes [38]. Purified MWNTs were then treated with nitric acid to introduce oxygen 
bearing functionalities (mainly carboxylic acid groups (−COOH)) onto the MWNT tips and 
sidewalls [39, 40]. SPION-MWNT hybrids containing increasing amount of iron content were 
synthesized in situ by mixing the functionalized MWNTs with a precursor for the formation 
of the nanoparticles. It is known that when metal salts are dissolved in the presence of acid 
treated nanotubes, the metal ions interact strongly with the surface groups present onto the 
MWNTs [41]. Such interactions were expected to occur in our samples when mixing iron 
acetate (precursor) with the functionalised MWNTs, thus affording a homogeneous coverage 
of the iron atoms onto the surface of the MWNTs. Subsequently, the samples were thermally 
treated and left exposed to air thus resulting in the formation of the iron oxide nanoparticles.
Physicochemical characterization of SPION-MWNT hybrids
The amount of SPION present in the hybrids was quantitatively determined by 
thermogravimetric analysis (TGA) carried out under flowing air (Fig. 1A). As shown in the 
TGA curves, oxidation of the samples took place at around 450 °C. Therefore, the residue 
obtained after the complete combustion of carbon atoms at 600 °C corresponded to the 
amount of iron oxide nanoparticles loaded onto the MWNTs. SPION-MWNT hybrids 
containing 11.5, 28.0, 41.5 and 48.0 wt% of SPION (assuming Fe2O3) were obtained and 
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named S-MWNT 1-4 respectively from now on, where S refers to the superparamagnetic 
properties of the iron oxide nanoparticles deposited on the MWNTs. The superparamagnetic 
properties are described in the later section. S-MWNT 4 was found to be physically unstable 
in aqueous dispersions, as will be described later, thus was disregarded in further studies. 
Magnetic measurements at 10 K were performed to evaluate the effect of the increasing 
amount of SPION. Fig. 1B shows the hysteresis loops for S-MWNT 1-3 and steam purified 
MWNTs which was included as a control. Purified MWNTs showed extremely weak 
magnetic signals, almost inappreciable in the figure, which was expected for samples with 
negligible catalytic impurities [42]. This was in agreement with TGA data under flowing air 
of the purified material that confirmed an almost unappreciable amount of residual metal 
catalyst (Fig. S1). Samples with a metallic content below 1 wt% are dubbed as “high 
quality” in terms of catalyst content (impurities from the synthesis of the carbon 
nanotubes [43]. In contrast to purified MWNTs, a marked ferromagnetic behavior was 
observed for hybrids S-MWNT 1-3 at 10K. As expected, samples with increasing amount of 
loaded SPION yielded higher saturation magnetization. Values for the saturation 
magnetization were measured as 6.5, 9.7 and 14.6 emu per total gram of sample (emu·g−1) 
for S-MWNT 1-3 respectively.
Phantom MR imaging and R2* relaxation measurements
The transverse R2* relaxation rates of S-MWNT 2-3 dispersed in 1% agar and 0.5% 
Pluronic® F127 solution at different Fe concentrations was measured at 7 Tesla (7T). 
Although the hybrids studied here displayed good dispersibility using 1% Pluronic® F127 
solution before dilution with agar, phantom samples were prepared by dispersing the 
materials in agar to avoid the sedimentation of samples and thus achieve more accurate 
relaxation measurements. The same preparation and measurements using Endorem®, a 
clinically approved SPION, were carried out for comparison. S-MWNT 1 with the lowest 
iron content was not investigated here since the dispersion was not ideal due to high sample 
concentrations required to achieve equivalent Fe amount to the other hybrids and thus for 
reliable MR imaging. Fig. 2A shows MRI of Endorem® (i) and S-MWNT 2- 3 (ii-iii) at 
different concentrations at an acquired echo time of 5 ms. Some of the vials reported none or 
little signal due to fast signal decay effects when imaged at increased echo times. By 
sampling such signal shortenings, R2* values were determined. The relaxation times of S-
MWNT 2-3 and Endorem® were plotted versus concentrations of iron (Fig. 2B), reporting 
good linear correlations. The r2* relaxivities were calculated as 343 s−1mM−1, 425 s−1mM−1 
and, 325 s−1mM−1 for S-MWNT 2-3 and Endorem® respectively. Endorem® reported the 
lowest r2* relaxivities while S-MWNT 3 showed the highest r2* making it an MR appealing 
probe for R2* and R2 investigations.
Characterization of S-MWNT 3
Further characterization was performed for S-MWNT 3 since it was found to be the hybrid 
with the best r2 relaxivity. Fig. 3A-B and Fig. S2 display transmission electron microscopic 
(TEM) images of S-MWNT 3 where SPION were shown along the backbone of the carbon 
nanotubes. High resolution TEM (HRTEM) analysis (Fig. 3C) confirmed the presence of 
crystalline nanoparticles attached to the walls of carbon nanotubes. Electron diffraction 
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analysis of these and other nanoparticles along with fast Fourier transform (FFT) 
simulations confirmed that the structure of the nanoparticles fit a cubic structure. The FFT 
pattern of one of the nanoparticles is shown as the inset in Fig. 3C. Indexation of this pattern 
and its corresponding simulation are in good agreement with the [−233] zone axis. This 
allowed us to narrow the nature of the SPION to either γ-Fe2O3 or Fe3O4, and all other 
oxide possibilities can be excluded.
The size of SPION that decorated MWNTs was determined based on TEM images analysis. 
The diameter of about 200 SPION was measured and the resulting histogram is presented in 
Fig. 4A. The majority of the SPION have diameters between 4-8 nm, with a mean value of 
6.5 ± 4.0 nm. The presence of small particles was responsible for the low signal to noise 
ratio showing in the X-ray diffraction (XRD) pattern of the hybrid (Fig. 4B). The observed 
peaks in Fig. 4B could be assigned to those of carbon (pdf –powder diffraction file– 750444) 
from carbon nanotubes and to either maghemite (γ-Fe2O3; pdf 391346) or magnetite (Fe3O4; 
pdf 740748). No peaks for iron (II) acetate which was used as a precursor were observed 
indicating a successful decomposition by the thermal treatment. Further evidence for the 
complete decomposition of iron acetate was provided by TGA analysis performed under 
flowing nitrogen where no weight loss at low temperature is observed (Fig. S3). The sharp 
drop at 710 °C for S-MWNT 3 was in good agreement with the % weight loss expected from 
the carbothermal reduction of the iron oxide nanoparticles by carbon (from the CNTs). 
Although the synthesis of the nanoparticles was performed under reducing conditions 
(Ar/H2 mixture), the posterior exposition of the samples in air led to the complete oxidation 
of the nanoparticles. X-ray photoelectron spectroscopy (XPS) was performed to get further 
insight into the nature of the nanoparticles. A cumulative detailed scan performed over the 
Fe 2p region is presented in Fig. 4C. The position, shape and width of the XPS peaks and the 
presence of the “shake-up” satellite structure at 719.3 eV is distinctive of the γ-Fe2O3 
structure [44].
In order to determine superparamagnetic properties of the SPION, hysteresis loops at 300 K 
were recorded. As shown in Fig. 4D, no remnant magnetization was observed when there 
was no applied magnetic field, which is the typical behavior of a superparamagnetic 
material. Collectively, it is confirmed that the MWNTs were decorated with 
superparamagnetic γ-Fe2O3 nanoparticles (SPION).
Radio-labelling efficiency and serum stability studies
Radio-labelling of SPION-MWNT hybrids was conducted as described previously using a 
functionalized bisphosphonate (BP) namely dipicolylamine-alendronate (DPA-ale) as a 
linker between SPION and the radioisotope 99mTc [34] (Scheme 1). DPA-ale is described as 
BP in the following sections. To investigate the possible influence of iron content on the 
radio-labelling efficiency, pristine MWNT (p-MWNT) without SPION and S-MWNT 1-3 
with increasing iron contents were radio-labelled. As shown in Fig. 5A, low radio-labelling 
efficiency was observed in p-MWNT in contrast to the S-MWNT hybrids where labelling 
yields were obtained above 57.5% ± 2.3. The low radio-labelling yield for p-MWNT could 
be due to non-specific adsorption of 99mTc-BP to the graphitic backbone of CNTs. The best 
labelling efficiency was achieved for S-MWNT 2 and 3 with values of 82.5 ± 3 % and 79.3 
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± 3 % respectively. The results indicated that, as expected, the amount of iron content has an 
impact on the radio-labelling efficiency, and hybrids with higher SPION contents exhibited 
higher radio-labelling yields.
Stability studies were assessed by incubating the labelled hybrids in either human serum or 
PBS (50% final concentration) at 37°C for 24 h. The results demonstrated high stability of 
all radio-labelled S-MWNTs in either human serum or PBS (Fig. 5B). Most of 99mTc was 
still bound to the hybrids (more than 90%) after 24 h incubation. Since S-MWNT 3 
displayed the best radio-labelling yields and stability in serum, it was selected to be used in 
the subsequent dual in vivo imaging and organ biodistribution studies.
Whole body 3D SPECT/CT imaging of mice injected with 99mTc-BP-S-MWNT 3
Whole body SPECT imaging in combination with computed tomography (CT) scanning was 
carried out to study the organ biodistribution of the radio-labelled 99mTc-BP-S-MWNT 3 (4 
MBq, 50 μg hybrid) or 99mTc-BP (5 MBq) alone at 30 min, 3 h and 24 h after i.v. injection 
in mice. As shown in the bottom panel in Fig. 6A, 99mTc-BP was mainly detected in bone at 
the early time points (< 30 min and 3 h) which is expected due to the high affinity of 
bisphosphonates to bone minerals [34]. Accumulation in kidney and bladder was detected in 
mice treated with 99mTc-BP within 30 min after injection suggesting rapid renal 
clearance. 99mTc-BP-S-MWNT 3, however, showed predominant accumulation in lung, 
followed by liver and spleen (top panel in Fig. 6A) within 30 min after injection. The signals 
in the liver remained constant after 4 h while a clear reduction in lung accumulation was 
observed over the first 4 h. Similar to 99mTc-BP, a small fraction was detected in the bladder 
after 30 min indicating rapid clearance for some 99mTc-BP-S-MWNT fractions. Low 
SPECT signals were detected in both mice at 24 h post administration (Fig. S5). The 
‘virtual’ loss of radioactivity is most likely due to the decay of the radionuclide (half-life 
for 99mTc, 6 h) as is the case of short half-lived radioisotopes. Therefore, post-mortem γ-
scintigraphy was conducted in parallel to SPECT/CT imaging to assess quantitatively the 
organ biodistribution of the hybrids over time.
Organ biodistribution and blood clearance profile of 99mTc-BP-S-MWNT 3 in mice after i.v. 
injection
Organ biodistribution of 99mTc-BP-S-MWNT 3 or 99mTc-BP alone in major mice organs 
was examined at 1, 4 and 24 h after i.v. injection. The results correlated well with the 
SPECT images that lung, liver and spleen were the major organs of accumulation (Fig. 6B 
and Fig. S6A). In view of organ biodistribution over time, the hybrid seemed to retain in 
liver and spleen tissues up to 24 h post injection as the percentage of injection dose (%ID) 
per gram tissue remained constant (Fig. 6B). Despite the reduction in %ID per gram lung 
tissue observed, substantial amount of the hybrid (i.e. 12.8% ± 1.9 ID/organ) was still 
detected in the lung after 24 h.
On the contrary, a markedly different organ biodistribution profile was observed for 99mTc-
BP. A typical bisphophonate pharmacokinetics was featured with profound accumulation in 
the bone and minimal exposure to other tissues (Fig. 6C and Fig. S6B). The results indicated 
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successful conjugation of 99mTc-BP to SPION-MWNT hybrids, as shown by the altered 
organ biodistribution pattern in vivo.
Different blood clearance profiles were found for 99mTc-BP and 99mTc-BP-S-MWNT 3 
(Fig. 6D). Despite less than 2.9% ± 0.3 of ID was measured in blood at 30 min after i.v. 
injection in the case of the hybrid, the amount of 99mTc-BP detected at the earliest time 
point (2 min) was approximately 3 times higher than that of 99mTc-BP-S-MWNT 3.
In vivo MR imaging and liver R2* relaxation time measurements
Since SPECT imaging demonstrated accumulation of the hybrid in the reticuloendothelial 
system (RES, e.g. liver and spleen), MRI was engaged in the liver in order to verify the 
correct multimodality effect of the hybrid. Fig. 7A shows axial liver images at different 
acquisition echo times against Fe concentration (mg/kg) of the hybrid. Like the results 
obtained in phantoms, MRI signals were darkened over time and the decay effects appeared 
faster upon increasing iron dosage. The R2* relaxation rate was plotted in Fig. 7B 
accordingly. The measured in vivo R2* relaxation rates from liver increased almost linearly 
in relation to the injected Fe doses.
Microscopic examination of S-MWNT 3 in tissues
To examine the presence of the hybrid in tissues after i.v. injection, tissues of lung, liver and 
spleen were sampled at various time points up to 30 days and stained by either Perls stain or 
Neutral Red stain. Mice were administered 400 μg of S-MWNT 3 (5.8 mg Fe/kg), a much 
higher dose than that used in biodistribution and SPECT studies, in order to be able to detect 
the hybrids by histological examination.
Perls stain is commonly used to demonstrate iron in tissues in histology. As shown in Fig. 
8A, blue staining indicating the presence of iron (shown by arrows) was observed in the 
three organs at 24 h, 7 days and 30 days. Spleen injected with the vehicle alone (1% 
Pluronic® F127 in PBS) lacking the SPION was shown to be the most positive to Perls stain. 
Moreover, a gradual increase in iron content over time was noted in spleen up to 30 days 
after injection and more iron was found in the red pulp region than white pulp. Red blood 
cells, which normally reside in the red pulp were stained with creamy brown colour (Fig. 
8A). On the contrary, the amount of iron in liver and lung declined over time since very few 
blue-stained regions were observed after 30 days. In comparison, no iron (blue stain) was 
observed in Pluronic® F127 liver tissues. It was also noted in the liver sections that more 
blue stain appeared in the cytoplasm of Kupffer cells compared to hepatocytes. This 
advanced uptake might be due to the phagocytic nature of Kupffer cells.
Separate tissue sections were then stained with Neutral Red as a counter stain to enable 
visualisation of the MWNTs [45, 46]. The results were in agreement with Perls stain that 
MWNTs (shown by arrows) showed the same pattern as iron in lung and liver with 
reduction observed in these tissues over time (Fig. 8B). MWNTs presented in spleen were 
also found in the red pulp region. Few batches of MWNTs remained in lung at 30 days and 
were shown as large aggregates.
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In summary, a good correlation was demonstrated in the organ biodistribution profile 
between the MWNTs and iron under microscopic examination, indicating a good stability of 
SPION-MWNT in vivo. Moreover, additional studies using TEM were carried out to 
confirm the integrity at the nanoscale level.
TEM studies of mice organs
To confirm the co-localisation of SPION and MWNT at ultra-structural levels, TEM 
examination for tissues sampled at 24 h after i.v. injection of 400 μg of S-MWNT 3 (5.8 mg 
Fe/kg) was carried out. Liver and spleen were chosen here as they showed high 
accumulation of the hybrid. Interestingly, the results confirmed uptake of the hybrid not only 
in kupffer cells but also in hepatocytes of the liver. A series of TEM images were taken for 
hepatocytes at different magnifications (Fig. 9A-B). Hepatocytes are recognised by the 
presence of a substantial number of mitocondria. The hybrids were often identified within 
vesicles. Both SPION and MWNTs were observed in the same endocytic vesicle, suggesting 
the uptake of MWNTs and SPIOs as an intact hybrid. SPION were shown as electron-dense 
particles (dotted black arrows) while MWNTs were confirmed with their tubular structures 
(solid black arrows). At 24 h, SPION were found dissociated from the MWNTs perhaps due 
to the low pH of endocytic vesicles. Fig. 9C-D show a kupffer cell (white dotted line), the 
professional macrophage cells located in liver, where a similar pattern to that of hepatocytes 
was observed. TEM images of spleen are shown in Fig. 9E-F. Again, SPION and MWNTs 
were observed in the same endocytic vesicles with some SPION being detached from 
MWNTs while some remained intact.
Co-localisation observed within the same endocytic vesicles indicated that the hybrids were 
stable enough to be able to pass through many biological barriers after i.v. administration, 
enter the same organ and to be internalised as intact hybrids by the same cell within the 
same endocytic vesicle.
Histological examination by H&E
Histological analysis was carried out on H&E stained paraffin embedded tissue sections 
sampled at various time points up to 30 days after i.v. injections of 400 μg S-MWNT 3 (5.8 
mg Fe/kg) (Fig. 10). No significant histological changes were observed in lung, liver and 
spleen compared to untreated tissues. Tissues taken from animals treated with 1% Pluronic® 
F127 solution alone were also examined and the results confirm no abnormalities induced. 
Such results indicated the biocompatibility of the hybrid in vivo under the conditions tested.
Discussion
The future of diagnostic applications lies on the use of multimodal approaches by combining 
different imaging modalities to achieve an accurate diagnosis in cancer, cardiovascular 
disease and other disorders. These attempts are to integrate the advantages of each imaging 
tool and compensate their limitations. The best example is the combination of SPECT/PET 
with MR or X-ray CT. As mentioned previously, the new generation of multimodal imaging 
equipment is the combination of MRI with SPECT/PET in which pioneer instruments 
designed for MR/PET hybrid imaging for human have been setup recently [47]. As a result, 
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the collected imaging outcomes would contain excellent tomography from MRI (resolution 
down to 50-250 μm) and great sensitivity achieved by SPECT/PET (10−10 to 10−12 mol/
L) [14]. Another important reason for these imaging techniques being used widely in the 
clinic is attributed to their unlimited penetration depth. This overcomes the major 
disadvantages of optical imaging techniques, particularly fluorescence detection, which is 
highly restricted to the location of the imaging targets, the type of light source used (e.g. 
laser wavelength), and intrinsic tissue properties (e.g. tissue absorption and scattering) [12].
A recently published study reported the synthesis of CNT/iron oxide hybrids by ligand 
exchange or clink chemistry approaches [48]. In the current study, SPION-MWNT hybrids 
were prepared by in situ generation. MWNTs were treated with acid to introduce oxygen 
bearing functionalities on the sidewalls and tips. The decoration of steam purified MWNTs 
(without the oxygen bearing functionalities) with iron oxide nanoparticles was also carried 
out as a control. The functionalization of the nanotubes was found to play a key role in 
providing a homogenous decoration with the nanoparticles. A more uniformed coverage of 
iron oxide nanoparticles was achieved when employing functionalized MWNTs compared 
to using the nanotubes lacking oxygen-containing functionalities. The use of iron acetate as 
a precursor was exploited for the formation of the iron oxide nanoparticles. The procedure 
involved thermal annealing at high temperature, resulting in the formation of nanoparticles 
with high crystallinity as confirmed by HRTEM. To determine the degree of nanoparticle 
loading, TGA under flowing air was performed. As appreciated in the TGA curves (Fig. 1A 
and Fig. S1), steam purified MWNT started to oxidize under flowing air at higher 
temperature (600 °C) than the S-MWNT 1-3 samples with oxidization starting at about 450 
°C. The decrease in the onset of combustion temperature, by about 150 °C, was due to the 
presence of inorganic nanoparticles in the samples. This phenomenon has been observed in 
samples of carbon nanotubes containing different inorganic materials [49]. Further 
characterization studies were carried out using HRTEM and XRD. HRTEM allows direct 
imaging and analysis of nanostructures and provides structural information down to the 
atomic scale. HRTEM analysis verified the presence of single-phase crystalline iron oxide 
nanoparticles and discarded the presence of core-shell nanoparticles (Fig. 3C) and the 
diffraction peaks shown in XRD also denoted the presence of carbon and Fe2O3/Fe3O4 in 
the bulk sample (Fig. 4B). However, both γ-Fe2O3 and Fe3O4 possess spinel structures that 
belong to the Fm-3d space group (cell parameter a(γ-Fe2O3) = 8.351 Å; a(Fe3O4) = 8.384 
Å) and their bulk saturation magnetization are also similar (Ms(γ-Fe2O3) = 87 emu g−1; 
Ms(Fe3O4) = 92 emu g−1)[50]. It also must be taken into account that the saturation 
magnetization of small nanoparticles is usually smaller than that of the bulk [51] which 
prevents the elucidation of the particle type from the performed magnetic measurements. 
Thus, it was not possible to elucidate the nature of the SPIOs based on diffraction studies 
and magnetic measurements. The nature of the iron oxide nanoparticles in the SPIO-MWNT 
hybrids studied was therefore investigated by XPS and identified to be γ-Fe2O3 (Fig. 4C). 
Magnetic measurements at 300 K confirmed that the γ-Fe2O3 nanoparticles possessed a 
superparamagnetic behaviour. Such temperature is close to room temperature i.e. 
administration condition therefore it was necessary to confirm that no remnant 
magnetization is present when the magnetic field is removed at such temperature.
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Phantom and in vivo MRI of S-MWNT hybrids were both conducted in this study. An 
intensive exploration of the R2* relaxation rate was carried out by imaging phantom samples 
containing different amount of iron prepared in 1% agar and 0.5% Pluronic® F127 solution 
(Fig. 2A). S-MWNT 2 containing 28 wt % SPION exhibited a similar r2* relaxivity to 
Endorem®, and S-MWNT 3 with increased SPION contents displayed a greater value than 
Endorem® (Fig. 2B). The phantom study reported r2* relaxivities of Endorem® which 
appeared to be higher than the values published in some other r2 studies [52, 53]. Such 
discrepancies are related to several factors. Firstly, R2* values reflect magnetic susceptibility 
effects which are largely avoided when engaging R2 sequences. R2* and R2 are significantly 
different at high magnetic fields making it difficult to compare. Although R2 is a more 
clinically relevant parameter than R2*, the latter provides higher sensitivity at high fields 
making it an ideal tool for iron oxide probes investigations. Secondly, the use of agar most 
probably speed up phantom signal decay thus enhancing r2* values. In fact, when 
investigating Endorem® in water at 7 T, a R2* value of 211.18 s−1mM−1 was obtained 
which agreed with what was reported in literature [54] (Fig. S4). It also should be mentioned 
that the relaxivity patterns observed when engaging R2* techniques should be similar to that 
observed when engaging R2 techniques, making, in our case, the S-MWNT 3 highly relevant 
to in vivo clinical studies. Most importantly, high r2* relaxivity of S-MWNT 3 implies that 
lower concentrations of the hybrids were required to achieve signals similar to that of 
Endorem®. Liver R2*-weighted MR imaging demonstrated time-dependent and 
concentration-dependent darkening in liver signals (Fig. 7A) and an almost linear R2* 
relaxation rate was obtained (Fig. 7B). Higher relaxation effects were observed in our in 
vivo liver experiment when compared to two previously reported studies that utilised an 
equivalent amount of injected Fe [19, 55]. A reduction of 60% in R2* was seen up to 5 h after 
injection of 2.5 Fe mg/kg compared to 69% reduction value obtained in our study at the 48 h 
imaging time point [19, 55]. In the second study, a reduction of 40% (at 2 h) at the dose of ~ 
2.8 mg Fe/kg was measured compared to 76.5% obtained in our study at the same dose (at 
48 h) [19, 55]. Despite the different imaging time points which do not allow a direct 
comparison to be performed, the results showed S-MWNT 3 enhanced liver MRI contrast 
and confirmed S-MWNT 3 to be suitable as a negative contrast agent.
As far as this study is concerned, this is the first study proving the bimodal MRI/SPECT 
imaging using SPION-CNT hybrids. Better radio-labelling efficiency was obtained for S-
MWNT 2-3 in contrast to S-MWNT 1 with lower SPION content (Fig. 5A). This confirmed 
the radio-labelling approach which introduced 99mTc-labelled BP to the SPION available on 
the carbon nanotube surface as opposed to non-selective adsorption of the radio-isotope to 
the MWNTs. Approximately, 80% labelling efficiency was already obtained for S-MWNT 2 
while no enhancement in radio-labelling was achieved in S-MWNT 3 despite of the 1.5 fold 
increase in iron content of the latter.
The results from SPECT/CT and organ biodistribution studies revealed most of the S-
MWNT 3 accumulated in lung, liver and spleen (Fig. 6). SPION is known to be taken up by 
liver and spleen (RES) hence it has been widely used to detect liver diseases by enhancing 
the negative MRI signals [56]. The prolonged uptake of CNT/iron oxide hybrids in lung has 
been reported [19]. The lung accumulation may be also due to their tubular and long 
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structure. Long fiber particles tend to cause pulmonary toxicity and fibres with the length 
longer than 10 μm were reported carcinogenic [57]. The mean length of the MWNTs was 
measured around 2 ± 1.8 μm (Fig. S1) and no histological abnormality was observed from 
different mice tissues treated with S-MWNT 3 up to 30 days. In a previous study, no 
physical abnormalities were detected after biochemical analysis of serum and urine samples 
of mice treated with various MWNTs with the length between 0.5 and 2 μm [58]. Preliminary 
in vitro cytotoxicity of S-MWNT 3 has been assessed using the mouse macrophage cell line 
J774 and no significant toxicity was measured at concentrations up to 100 μg/ml after 24 h 
incubation (unpublished data). Work is currently being undertaken to investigate and 
compare the MR properties of S-MWNT hybrids with different lengths in vitro and in vivo.
The reduction in S-MWNT 3 accumulation in lung and liver over time was confirmed by 
microscopic examination of the tissue sections stained with Perls stain and Neutral Red to 
detect the presence of iron oxide or MWNTs respectively (Fig. 8). Unlike lung and liver, 
contradictory results were obtained in spleen sections following two staining methods where 
an increase in Perls stain-positive regions were captured up to 30 days while a reduced level 
of MWNTs was observed in Neutral Red stain. Iron stains were mostly found in the red 
pulps of spleen. With this regard, spleen is one of the iron storage organs in the body and 
therefore the red pulps are often Perls stain-positive. Therefore, the blue stains in spleen 
could be attributed to the iron from S-MWNT hybrids or the natured iron resulted from 
heme oxidation from dead red blood cells.
TEM examination was further carried out for observation of S-MWNT hybrids in tissues at 
ultra-structural scale. The observation of SPION-CNT hybrids in vitro by TEM has been 
reported previously [48]. Prostate cancer cells were incubated with the hybrids for 20 h and 
TEM images revealed their localisation in endosomes/lysosomes as bundles or individual 
tubes. Iron oxide nanoparticles were still attached with CNTs at this time point after cellular 
internalisation. In another study, Wu et al. have used TEM to validate the presence of 
MWNT/iron oxide constructs in tissues at 4 h after injection [19]. In the present study, more 
detailed information on cellular localisation of S-MWNT hybrids was disclosed in which 
colocalisation of SPION and MWNTs within the same endocytic vesicles was clearly 
observed in spleen cells, liver hepatocytes and kupffer cells at 24 h after injection (Fig. 10). 
The results provided sufficient evidence of the in vivo stability of S-MWNT oxide hybrids 
so that they were taken up by the same cells as intact hybrids after intravenous injection. The 
detachment of SPION from MWNTs was also observed which might be due to the acidic 
environment of these vesicles.
As mentioned previously, CNTs have been developed for biomedical imaging 
applications [7] and we have also radio-labelled CNTs with Indium-111 [45, 59] or filled 
Iodine-125 inside the tube [46] for in vivo imaging and biodistribution studies. The current 
study presented 99mTc-labelled SPION-MWNT hybrids as dual MRI and SPECT contrast 
agents for the first time. The beauty of the design in this construct is the ease in preparation 
forming a stable construct capable of MRI and SPECT imaging upon reaction with a BP 
derivative. The BP derivative could be altered so that different radio-isotopes can be 
utilized [36, 60] allowing for SPECT or PET imaging, both considered to be clinically very 
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important modalities in disease diagnosis, staging and monitoring. The current study 
certainly assures a new prospect for CNTs application in the biomedical imaging field.
Conclusions
The present study has developed novel radio-labeled and iron oxide nanoparticle decorated 
multi-walled carbon nanotubes (SPION-MWNT) hybrids for dual MR and SPECT imaging. 
Efficient and homogeneous loading of SPION were achieved via in situ generation, followed 
by thorough characterizations of physiochemical and magnetic properties. In MRI studies, 
the resulting SPION-MWNT showed reduction of T2* signals in both phantom and liver 
equivalent in efficacy to clinically approved MRI contrast agents. Radio-labeling of SPION-
MWNT with 99m-Tc through a functionalized bisphosphonate was reported for the first time, 
permitting in vivo 3D whole body SPECT/CT imaging and profiling biodistribution pattern 
quantitatively. The TEM observations of SPION and MWNT co-localizing intracellularly in 
the same vesicles in liver and spleen tissues denoted the in vivo stability. No abnormality 
found up to 30 days after i.v. injection in histological investigation showed a good 
biocompatibility behavivor of the hybrids. Findings from this work demonstrated the 
capability of SPION-MWNT hybrids for dual-modality MR-SPECT imaging and broaden 
the spectrum of CNT applications in biomedical imaging field.
Materials and Methods
Materials
Chemical vapour deposition multi-walled carbon nanotubes (MWNTs) were supplied as a 
dry powder (Thomas Swan & Co. Ltd, UK) with an external average diameter of 10-12 nm 
(information provided by the supplier). Iron acetate (III), human serum from human male 
AB plasma, Pluronic® F127, agar, 10% neutral buffered formalin, and Perls stain kits were 
purchased from Sigma-Aldrich (Sigma- Aldrich, UK). Endorem® was obtained from 
Guerbet (Guerbet Laboratories, UK). Dipicolylamine-alendronate (DPA-ale or BP) 
and 99mTc -BP were synthesized as previously reported [27]. Na[99mTcO4] in physiological 
saline was obtained from a 99Mo/99mTc generator at the Radiopharmacy at Guy’s and St 
Thomas’ Hospital NHS Trust, London, UK. Radioactivity in samples was measured using a 
CRC-25R dose calibrator (Capintec, USA) or a 1282 CompuGamma gamma counter (LKB 
Wallac, PerkinElmer, USA). [99mTc (CO)3(H2O)3]+ was synthesized using Isolink™ kits 
(Mallinckrodt Medical B.V., St. Louis, MO, USA). C57/Bl6 female mice aged 6-8 weeks 
were used throughout the in vivo studies and were obtained from Harlan Laboratories. 
Isoflurane for anaesthesia was purchased from Abbott (IsoFlo®, Abbott Laboratorie Ltd, 
UK) and pentobarbital sodium used for lung inflation fixation was from Merial (Euthatal®, 
Merial Animal Health Ltd, UK). For sample preparation for histological and TEM 
examination, xylene, ethanol and sodium cacodylate were purchased from Fisher Scientific, 
DPX used for mounting was obtained from VWR International Ltd, EM grade glutaldehyde 
was from Merck, and Araldite CY212, tris(dimethylaminomethyl)phenol (DMP30) 
dodecenyl succinic anhydride (DDSA) were purchased from Agar Scientific.
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Synthesis of SPION-MWNT hybrids
The as-received MWNTs were purified by steam following a previously reported 
protocol [30]. Briefly, MWNTs were ground with an agate mortar and pestle until a fine 
powder was obtained. Next, the MWNT sample was spread inside a silica tube (about 40 
mm in diameter) which was then introduced into a furnace alumina tube. Steam was 
introduced by bubbling argon (150 mL min−1) through a flask containing hot distilled water 
(98°C). The whole system was initially purged with argon for 2 h to ensure the complete 
removal of oxygen, before heating the furnace to 900°C during 1.5 h to allow the 
purification of the material. The solid powder was collected and treated with 6 M HCl to 
remove the now exposed metal nanoparticles [33]. The purified MWNTs were collected by 
filtration through a 0.2 μm polycarbonate membrane and thoroughly washed with water until 
pH neutral. The purified MWNTs were then functionalized by refluxing with 3 M HNO3 for 
45 h, resulting in the introduction of carboxylic acid groups (−COOH) onto the MWNT tips 
and side walls [32]. The functionalized MWNTs (f-MWNTs) were collected by filtration and 
washed with water until neutral pH was achieved.
Decoration of the MWNTs with SPION was carried out in situ where SPION were prepared 
in the presence of the f-MWNTs. Iron (II) acetate was employed as the iron precursor for the 
formation of the SPION since it is water soluble and can be decomposed by thermal 
annealing. Samples with increasing amount of iron contents were prepared and the loading 
of SPION onto the MWNTs was subsequently determined. Iron (II) acetate (10, 20, 40, and 
50mg) was added to a round-bottomed flask containing 25 mg of functionalized MWNTs 
and 15 mL of distilled water. The mixture was bath sonicated for 10 min and stirred at 60°C 
for 16 h to allow a uniform coverage of iron (II) acetate onto the surface the MWNTs. 
Solutions were left to cool down and filtered through a 0.2 μm polycarbonate membrane. 
Samples were then treated with Ar/H2 at 500°C for 2 h and left exposed in air thus affording 
the formation of the SPION on MWNTs surface.
Analysis and characterisation of SPION-MWNT
Thermogravimetric analyses were performed under flowing air at a heating rate of 10°C/min 
up to 950°C (Jupiter®, Netzsch Instrument, Germany). X-Ray diffraction studies were 
conducted using a powder diffractometer (CuKα1, λ = 0.1540nm; Siemens D5000, 
Germany) with 2θ ranging from 5° to 65°. The PDF (Powder Data File) database was used 
to identify the compounds. For transmission electron microscopy studies, samples were 
prepared by dispersing a small amount of powder in absolute ethanol and sonicated using an 
ultrasonic power bath. The dispersions were placed dropwise onto lacey carbon grids. Low 
magnification TEM images were obtained using a JEOL 1210 transmission electron 
microscope (JEOL SAS, Japan) operating at 120 kV and high resolution TEM analysis was 
performed in an FEI Tecnai G2 microscope operating at 200 kV (Titan, FEI, the 
Netherlands). X-ray photoelectron spectra (XPS) were acquired with a Kratos AXIS ultra 
DLD. The magnetic moment of the samples was measured using a superconducting quantum 
interference device (SQUID, LOT-QuantumDesign Iberia, Spain) magnetometer. Each 
sample was placed into a diamagnetic gelatine capsule. Data was acquired with an applied 
field from −50000 Oe to 50000 Oe at temperatures of 10 K and 300 K. The sample holder 
contribution was subtracted in all the measurements.
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Preparation of SPION-MWNT hybrids dispersions for MR studies
SPION-MWNT hybrids dispersed in 1% Pluronic® F127 solution were mixed with an equal 
volume of agar solution (2%, w/v in water) at 95°C. Samples dispersions prepared at a range 
of Fe concentrations up to 1.25 mM were transferred to 0.3mL microtubes within less than 
one minute before gel solidification occurs. Phantoms were imaged by MRI as described 
below.
MR imaging
Phantom and in vivo MR imaging were performed at a 7T horizontal MR scanner (Agilent, 
Palo Alto, CA). The gradient coil had an inner diameter of 12 cm, gradient strength was 
1000 mT/m (100 G/cm) and rise-time of 120 μs. A quadrature transmit/receive coil (RAPID 
Biomedical GmbH, Germany) with an internal diameter of 39 mm was used. Animals were 
intravenously injected with 0.72- 4.4 mg Fe/kg S-MWNT 3 and imaged at 48 h post 
injection. This range of injection doses was chosen as reported in several pre-clinical 
studies [19, 28]. Animals were imaged in prone position under constant anesthesia of 1.5% 
isoflurane / 98.5% oxygen. Body temperature was maintained constant at 37°C using a 
warm air fan and ECG and respiration monitored (SA Instruments, Stony Brook, NY). R2* 
imaging was used in this study as it does not only reflect the spin-spin relaxation but also 
takes into account the magnetic field inhomogeneity. Cine-FLASH MRI technique with 
variable echo time (TE) was used to acquire R2* images and such methods were adopted 
both in vitro and in vivo. The cine-FLASH parameters for R2* images in phantoms were: 
FOV = 30 × 30 mm, matrix size = 96 × 96, slice thickness = 1 mm; number of slice = 1; flip 
angle = 20°, 1 average, TR = 700 ms; TE = 1, 2, 3, 5, 8, 10 ms; scan time ~ 7 min. Cine-
FLASH parameters for in vivo R2* acquisitions were: FOV = 25× 25 mm, matrix size = 128 
× 128, slice thickness = 1 mm; flip angle = 20°; number of slice = 1; 1 average; TR = 1 / 
heart rate = RR-interval; TE = 1, 2, 3, 5 ms; scan time ~ 10 min. A short-axis and a long axis 
view were used for the in-vivo experiment.
MR Image analysis
MR images were analyzed using the ImageJ software (NIH, USA). R2* pixel by pixel data 
was fitted by the following equation:
(1)
Where Sn is the signal measured, S0 is the initial signal and TEn represents the different 
echo spacing. By selecting a region of interest (ROI) within the phantom area or, for in-vivo 
studies, within the liver area, the software automatically calculates mean R2* values. R2* 
values were plotted using Excel versus the corresponding iron concentrations. Results are 
presented as mean ± S.D. (n=3). In phantom studies such plot resulted in a linear 
relationship where the slopes corresponded to the r2*relaxivities.
Radio-labelling of S-MWNT hybrid 1-3
The labelling of SPION-MWNT hybrids with 99mTc-BP was carried out as previously 
reported by de Rosales et al [26, 28]. Hybrids with different iron contents were tested initially 
to optimise the radio-labelling efficiency. S-MWNT 1-3 (125 μg/125 μL) were first 
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dispersed by sonication (10 min) in 1% Pluronic® F127 solution at 1 mg/mL concentration 
and mixed with 1-10 MBq 99mTc-BP (500 MBq in 50 μg of BP/125 μL). The mixture was 
incubated at 37°C for 30 min with gentle shaking. After cooling to room 
temperature, 99mTc-BP-S-MWNT hybrids were separated from unbound 99mTc-BP by 
centrifugation at 17,000 rcf for 10 min and the pellets containing 99mTc-BP-S-MWNT 
hybrids were washed 4 times (1 mL each wash) with 1% Pluronic® F127 until no 
radioactivity was detected in the supernatant. The total radioactivity in the supernatants and 
the pellet were measured to determine the radio-labelling efficiency. The pellet was then re-
dispersed using 1% Pluronic® F127 solution to achieve a final concentration of 1 mg/ml for 
subsequent in vivo studies (γ-scintigraphy and SPECT/CT imaging).
In vitro stability in PBS and human serum
To assess the in vitro stability of the radio-labelled hybrids, 99mTc-BP-S-MWNT 1-3 were 
mixed with an equal volume of human serum or PBS (at 50% final concentration) and 
incubated at 37°C under constant shaking for 24 h. The samples were then centrifuged at 
17,000 rcf for 10 min. The radioactivity of the pellets and the supernatants were measured 
by gamma counting to determine the percentage of 99mTc-BP remained bound to the S-
MWNT hybrids representing stably labelled hybrids.
Whole body 3D SPECT/CT imaging of mice injected with 99mTc-BP-S-MWNT 3
All in vivo experiments were conducted under the authority of project and personal licences 
granted by the UK Home Office and the UKCCCR Guidelines (1998). C57/Bl6 mice were 
anaesthetised by isofluorane inhalation and injected intravenously with 50 μg of 99mTc-BP-
S-MWNT 3 or 99mTc-BP in 1% Pluronic® F127 solution containing approximately 5 MBq. 
SPECT imaging was carried out immediately after injection with images taken in 16 
projections over 30 min using a four-head scanner with 1.4mm pinhole collimators (Nano-
SPECT/CT scanner, Bioscan, USA). CT scanning was performed with a 45 kV X-ray source 
and 1000 ms exposure time over 10 min at the end of each SPECT acquisition. SPECT and 
CT images were reconstructed using the MEDISO software (Medical Imaging Systems) and 
then merged by the InVivoScope™ software (Bioscan, USA). Each animal was recovered 
and further imaged at 4 h and 24 h.
Organ biodistribution of 99mTc-BP-S-MWNT 3 in mice by gamma scintigraphy
The pharmacokinetic studies including the blood circulation and organ biodistribution of the 
hybrid were carried out using female C57/Bl6 mice (6-8 weeks old). Mice were given 50 μg 
of 99mTc-BP-S-MWNT 3 or 99mTc-BP (250 μL in 1% Pluronic® F127 solution) 
intravenously via tail vein. The blood clearance profile was established by collecting blood 
samples in heparinised capillaries from 2 min up to 24 h after injection. For organ 
biodistribution study, major organs including skin, liver, spleen, heart, lung, muscle, bone, 
brain, stomach and intestine were excised post mortem at 1 h, 4 h and 24 h after injection. 
Samples were weighed and the radioactivity was detected, quantified and corrected for 
physical radioisotope decay by gamma scintigraphy. The % ID per organ and per gram 
tissue were calculated and plotted as the mean of triplicate or quadruplicate samples ± SD.
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Histological analysis
For histological examination of organs, C57/Bl6 mice were injected via tail vein with 400 μg 
of S-MWNT 3 (5.8 mg Fe/kg) dispersed in 1% Pluronic® F127 solution and tissues of lung, 
liver and spleen were excised at 24 h, 7 days and 30 days after injection. Lung tissues were 
sampled by an inflation-fixation method. Mice were given an overdose of pentobarbital 
sodium intraperitonealy and a small incision in the midline of the trachea was performed. A 
24 gauge catheter (Angiocath™, BD Biosciences, UK) was placed in the mouse trachea and 
a solution of 5 ml 10% neutral buffered formalin (Sigma-Aldrich, UK) was directly instilled 
into the lung using a syringe. Entire inflated lung was removed and stored in 10% neutral 
buffer formalin. Other organs were immediately fixed in 10% neutral buffer formalin as 5 
mm2 pieces. Samples were then wax-embedded and sectioned for haematoxylin and eosin 
stains (H&E) or Neutral Red stains according to standard histological protocols at the Royal 
Veterinary College.
To detect the presence of iron in tissues, Perls staining was carried out using a Perls stain kit 
used according to the manufacturer’s instruction. In brief, sections were deparaffinised and 
incubated with potassium ferrocyanide solution for 20 min followed by counterstaining with 
nuclear red solution for 10 min. Sections were then dehydrated using increasing 
concentrations of ethanol solutions (70%, 90% and absolute ethanol), cleared by xylene and 
mounted in DPX.
All stained sections were analysed using a Leica DM 1000 LED Microscope (Leica 
Microsystems, UK) coupled with CDD digital camera (Qimaging, UK).
TEM examination of S-MWNT 3 in liver and spleen tissues
Mice were injected with 400 μg of S-MWNT 3 (5.8 mg Fe/kg) dispersed in 1% Pluronic® 
F127 solution. At 24 h, mice were killed and liver and spleen were rinsed by PBS. Organs 
were excised into 2 mm thin pieces and fixed in 2.5 % EM grade glutaldehyde in 0.1M 
sodium cacodylate buffer for 24 h. Liver and spleen samples were then transferred to 0.1M 
sodium cacodylate buffer and stored at 4°C until further processing. Samples were fixed 
using 1% osmium oxide solution for 3h. The samples were rinsed with 0.1M cacodylate 
buffer and de-hydrated using increasing concentrations of ethanol solutions (70%, 90% and 
absolute ethanol). Propylene oxide was added to the samples for 15 min, followed by 
infiltration in 1:1 mixture of propylene oxide: epoxy resin (Araldite CY212, DDSA and 
DMP30) overnight. The samples were then embedded into epoxy resin blocks and left in 
60°C oven for 3 days to polymerise. Ultrathin sections were cut on a microtome (Leica 
Reichert Ultracut) using a diamond knife and collected on 300-mesh copper grids. The grids 
were stained using uranyl acetate and imaged using a FEI/Philips CM12 transmission 
electron microscope (FEI, the Netherlands) at 80kV.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Physicochemical characterisation of SPION-MWNTs hybrids
(A) Thermogravimetric analysis of S-MWNTs in flowing air; (B) Hysteresis loops of S-
MWNT 1-3 at 10 K after subtracting the linear background; purified MWNTs were included 
for comparison.
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Fig. 2. Phantom MR imaging studies
(A) Phantom MR imaging of Endorem® (i) and S-MWNT 2- 3 (ii-iii). Samples are arranged 
clockwise from lowest (brightest) to highest (white arrows) iron concentration; (B) R2* 
relaxation time analysis as a function of Fe concentration. A 7 Tesla magnet was engaged 
for image acquisition. r2* relaxivities of the hybrids were obtained from the different slopes. 
Results are presented as mean ± S.D. (n=3).
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Fig. 3. Transmission Electron Microscopy analysis of S-MWNT 3
(A, B) TEM images at two different magnifications; and (C) A high resolution transmission 
electron microscopy (HRTEM) image of S-MWNT 3; the inset presents the diffraction 
pattern of a nanoparticle and the simulated diffraction pattern along the zone axis [−233].
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Fig. 4. Characterization of the iron oxide nanoparticles decorating MWNTs
(A) Histogram of the nanoparticle size, (B) X-ray diffraction pattern, (C) X-ray 
Photoelectron Spectroscopy, (D) Hysteresis loops at 300 K.
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Fig. 5. Radio-labelling efficiency and stability of SPION-MWNT hybrids
(A) Radio-labelling efficiency of pristine MWNT (p-MWNT) and S-MWNT 1-3. Hybrids 
dispersed in 1% Pluronic® F127 solution at 1 mg/mL concentration were mixed with 99mTc-
BP at 37°C for 30 min. Radio-labelling efficiency was estimated by measuring the 
radioactivity in the pellets (bound 99mTc-BP) and supernatants (unbound 99mTc-BP) of the 
samples after centrifugation at 17,000 rcf for 30 min. (B) Serum (50%) and PBS stability 
studies of radio-labelled S-MWNT 1-3 after 24 h incubation at 37°C.
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Fig. 6. In vivo SPECT/CT and organ biodistribution studies following i.v. injection of 99mTc-BP-
S-MWNT 3 or 99mTc-BP
(A) Whole body 3D SPECT/CT imaging; (B) organ biodistribution of 99mTc-BP-S-MWNT 
3 and (C) 99mTc-BP. (D) Blood clearance profile of 99mTc-BP-S-MWNT 3 and 99mTc-BP. 
Cross sections in (A) were taken at lung (LU), liver (LI), spleen (SP), kidney (KI) and 
bladder (BL). Results are expressed as mean ± S.D. (n=3).
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Fig. 7. In vivo R2*-weighted MR studies
(A) MR images of mouse liver 48h after injection with various doses of S-MWNT 3 over 
time; (B) R2* relaxation rate measurements. L: liver.
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Fig. 8. Microscopic examination of liver, lung and spleen sections of C57/Bl6 mice injected with 
S-MWNT 3
Animals were injected with the vehicle alone (1% Pluronic ® F127) or 400 μg of the hybrid 
(5.8 mg Fe/kg). Selected organs were sampled at 24 h, 7 days and 30 days after injection and 
stained with (A) Perls staining or (B) Neutral Red staining. Arrows in (A) point the presence 
of iron (blue colour) and arrows in (B) point the presence of carbon nanotubes (black dots) 
in the tissue sections. W: the white pulp region of spleen; R: the red pulp region of spleen. 
The scale bar corresponds to 50 μm.
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Fig. 9. TEM micrographs of liver and spleen sections from animals injected with S-MWNT 3 at 
24 h
Animals were injected with 400μg of S-MWNT 3 (5.8 mg Fe/kg) via a tail vein. Organs 
were excised, fixed in 3% glutaldehyde in 0.1M cacodylate buffer and sectioned for TEM. 
The presence of S-MWNT was identified in hepatocytes (A-B) and kupffer cells outlined in 
(C-D) and spleen (E-F). (B) and (D) are higher magnification images from the inset 
rectangles in (A) and (C) respectively. Dashed arrows point SPION and solid arrows point 
MWNTs. Mit: mitochondria. Bars are 2 μm in (A) and (C), 0.5 μm in (B) and (D) and, 1 μm 
in (E) and (F).
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Figure 10. Histological examination of liver, lung and spleen sections of C57/Bl6 mice injected 
with S-MWNT 3
Animals were i.v. injected with 400 μg of the hybrid (5.8 mg Fe/kg). Organs were sampled 
at 24 h, 7 days and 30 days, fixed, paraffin embedded and sectioned for H&E staining. 
Animals injected with 1% Pluronic® F-127 were included as controls (at 24 h). The scale 
bar corresponds to 50 μm. No histological abnormalities were observed in all the organs 
examined up to 30 days.
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Scheme 1. Radio-labelling of SPION-MWNT hybrids with technetium-99m (99mTc) via a linker
The Radio-labelling was conducted using 99mTc-dipicolylamine-alendronate (99mTc-DPA-
ale, referred to 99mTc-BP thereafter) as described previously [34].
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